Cargando…

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?

Detalles Bibliográficos
Autores principales: Honore, Patrick M., De Bels, David, Attou, Rachid, Redant, Sebastien, Gallerani, Andrea, Kashani, Kianoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532174/
https://www.ncbi.nlm.nih.gov/pubmed/31118066
http://dx.doi.org/10.1186/s13054-019-2469-7
_version_ 1783420961954988032
author Honore, Patrick M.
De Bels, David
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
Kashani, Kianoush
author_facet Honore, Patrick M.
De Bels, David
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
Kashani, Kianoush
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-6532174
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65321742019-05-28 Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker? Honore, Patrick M. De Bels, David Attou, Rachid Redant, Sebastien Gallerani, Andrea Kashani, Kianoush Crit Care Letter BioMed Central 2019-05-22 /pmc/articles/PMC6532174/ /pubmed/31118066 http://dx.doi.org/10.1186/s13054-019-2469-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Honore, Patrick M.
De Bels, David
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
Kashani, Kianoush
Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
title Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
title_full Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
title_fullStr Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
title_full_unstemmed Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
title_short Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
title_sort endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532174/
https://www.ncbi.nlm.nih.gov/pubmed/31118066
http://dx.doi.org/10.1186/s13054-019-2469-7
work_keys_str_mv AT honorepatrickm endocanremovalduringcontinuousrenalreplacementtherapydoesitaffectthereliabilityofthisbiomarker
AT debelsdavid endocanremovalduringcontinuousrenalreplacementtherapydoesitaffectthereliabilityofthisbiomarker
AT attourachid endocanremovalduringcontinuousrenalreplacementtherapydoesitaffectthereliabilityofthisbiomarker
AT redantsebastien endocanremovalduringcontinuousrenalreplacementtherapydoesitaffectthereliabilityofthisbiomarker
AT galleraniandrea endocanremovalduringcontinuousrenalreplacementtherapydoesitaffectthereliabilityofthisbiomarker
AT kashanikianoush endocanremovalduringcontinuousrenalreplacementtherapydoesitaffectthereliabilityofthisbiomarker